Treatment of slow-channel congenital myasthenic syndrome in a Thai family with fluoxetine.
Dejthevaporn C, Wetchaphanphesat S, Pulkes T, Rattanasiri S, Engel AG, Witoonpanich R.
J Clin Neurosci. 2022 Feb;96:85-89. doi: 10.1016/j.jocn.2021.12.016. Epub 2022 Jan 6.
Slow-Channel Congenital Myasthenic Syndrome Due to the Novel Variant c.1396G_A in CHRNA1 That Responds Favorably to 3,4-Diaminopyridine: A Case Report.
Finsterer J.
Cureus. 2024 Nov 13;16(11):e73601. doi: 10.7759/cureus.73601. eCollection 2024 Nov.
Congenital myasthenic syndromes.
Beeson D.
Handb Clin Neurol. 2024;203:69-88. doi: 10.1016/B978-0-323-90820-7.00013-6.
Fluoxetine is neuroprotective in slow-channel congenital myasthenic syndrome.
Zhu H, Grajales-Reyes GE, Alicea-Vázquez V, Grajales-Reyes JG, Robinson K, Pytel P, Báez-Pagán CA, Lasalde-Dominicci JA, Gomez CM.
Exp Neurol. 2015 Aug;270:88-94. doi: 10.1016/j.expneurol.2014.10.008. Epub 2014 Oct 23.
Acquired slow-channel syndrome.
Scola RH, Werneck LC, Iwamoto FM, Comerlato EA, Kay CK.
Muscle Nerve. 2000 Oct;23(10):1582-5. doi: 10.1002/1097-4598(200010)23:10<1582::aid-mus16>3.0.co;2-h.
[Clinical and genetic analysis of a patient with slow-channel congenital myasthenic syndrome].
Liu Y, Ye S, Zhang H, Zhang K, Lyu Y, Gao M, Gai Z, Liu Y.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 2020 May 10;37(5):551-554. doi: 10.3760/cma.j.issn.1003-9406.2020.05.014.
Slow-Channel Congenital Myasthenic Syndrome due to a Novel Mutation in the Acetylcholine Receptor Alpha Subunit in a South Asian: A Case Report.
Gooneratne IK, Nandasiri S, Maxwell S, Webster R, Cossins J, Beeson D, Gunaratne K, Herath L, Senanayake S, Chang T.
J Neuromuscul Dis. 2021;8(1):163-167. doi: 10.3233/JND-200566.
Molecular Pathophysiology of Congenital Long QT Syndrome.
Bohnen MS, Peng G, Robey SH, Terrenoire C, Iyer V, Sampson KJ, Kass RS.
Physiol Rev. 2017 Jan;97(1):89-134. doi: 10.1152/physrev.00008.2016.
Adult-onset vocal cord paralysis in slow-channel congenital myasthenic syndrome.
Nakamura H, Komiya H, Uematsu E, Nakae Y, Tanaka K, Kunii M, Tada M, Joki H, Koyano S, Matsumoto N, Doi H, Takeuchi H, Tanaka F.
Neurol Clin Pract. 2019 Oct;9(5):e45-e47. doi: 10.1212/CPJ.0000000000000599.
Slow Channel Syndrome Revisited: 40 Years Clinical Follow-Up and Genetic Characterization of Two Cases.
Boon HTM, Jacobs B, Wouter VR, Kamsteeg EJ, Kuks JBM, Vincent A, Eymard B, Voermans NC.
J Neuromuscul Dis. 2022;9(4):525-532. doi: 10.3233/JND-220798.
